DJIA 15,973.84 313.66 2.00%
NASDAQ 4,337.51 70.68 1.66%
S&P 500 1,864.78 35.70 1.95%
market minute promo

ONCONOVA THERAPEUTICS INC (NASDAQ: ONTX)

0.45 0.01 (2.30%)

Quote as of


company name or ticker

Recent Quotes

ONTX $0.45 2.30%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.46
Previous Close $0.44
Daily Range $0.45 - $0.56
52-Week Range $0.32 - $4.00
Market Cap $11.2M
P/E Ratio -0.24
Dividend (Yield) $0.00 (0.0%)
Volume 156,481
Average Daily Volume 79,092
Current FY EPS -$1.49

Sector

Industry

ONCONOVA THERAPEUTICS INC (ONTX) Description

ONCONOVA THERAPEUTICS INC Website: http://www.onconova.com/

News & Commentary Rss Feed

This Week in Biotech: Buyouts, an FDA Approval, and Clinical Data. Oh, My!

A $25 billion buyout, a long-awaited FDA approval, two positive clinical studies, and one biopharma losing 37% of its value, are this week's top biotech stories.

Health Care Sector Update for 12/08/2015: GALE, LGND, ONTX

Benzinga's Top #PreMarket Gainers

Onconova Presents Positive Data rom Phase 2 Combination Trial of Oral Rigosertib and Azacitidine at

Onconova Presents Positive Data rom Phase 2 Combination Trial of Oral Rigosertib and Azacitidine at #ASH2015

Pacira Tops Q3 Earnings & Revenues, Exparel in Focus

Health Care Sector Update for 10/09/2015: ONTX,CHEK,LDRH

Onconova Therapeutics Files European Clinical Trial Applications for Global Phase 3 Trial for IV Rig

Onconova Therapeutics Files European Clinical Trial Applications for Global Phase 3 Trial for IV Rigosertib in Higher-Risk Myelodysplastic Syndromes

Onconova Therapeutics (ONTX) Is Today's Strong On High Volume Stock

Onconova Files IND Application for Rigosertib, Shares Jump

Today's Weak On High Volume Stock: Onconova Therapeutics (ONTX)

Morning Market Losers

See More ONTX News...